ESEF — Europäische Jahresabschlüsse (iXBRL) fact · reporting period
Ascelia Pharma AB: ifrs:AdjustmentsForIncreaseDecreaseInOtherLiabilities
One fact, its scope and the complete path back to the official record.
Reported value
3.094M{"amount": 3094000.0}- Entity
- Ascelia Pharma AB
- Metric
- ifrs:AdjustmentsForIncreaseDecreaseInOtherLiabilities
- Period
- 2020-01-01 – 2020-12-31
- Status
- current
- Source
- ESEF — Europäische Jahresabschlüsse (iXBRL)
Provenance
Official reference
esef:5493002YR9VCJJPWYN08:2021-12-31Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-24T01:38:06.089351+02:00
Raw response SHA-256
083ee476e82e5bf5489f72adcba22f97…History
- no predecessors — first report
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.